Updated review of the pathogenesis and management of merkel cell carcinoma

Journal of Cutaneous Medicine and Surgery

Volumn 14, Issue 2, 2010, Pages 51-61

  Zampetti, Anna ^a   Feliciani, Claudio ^a   Massi, Guido ^a   Tulli, Antonello ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; TAXANE DERIVATIVE; TOPOTECAN; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DISTANT METASTASIS; ELECTRON MICROSCOPY; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MERKEL CELL TUMOR; MOLECULAR BIOLOGY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SELF EXAMINATION; SKIN CARCINOGENESIS; SKIN EXAMINATION; SKIN SURGERY;

EID: 77950802414     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2010.09017     Document Type: Review

References (103)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972;105:107-110
2. O'Connor WJ, Broadland D. Merkel cell carcinoma. Dermatol Surg 1996;22:262-267
3. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999;8:153-158
4. Silva EG, Mackay B, Goepfert H, et al. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol Annu 1984;2:1-28.
5. Mills LA, Durrani AJ, Watson JD. Merkel cell carcinoma in South East Scotland 1993-2003. Surgeon 2006;4:133-138
6. Boyle F, Pendleburt S, Bell D. Further insight into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys 1995;31:315-323
7. Hitchcock CL, Bland KI, Laney RG III, et al. Neuroendocrine (Merkel cell carcinoma) of the skin. Its natural history, diagnosis and treatment. Ann Surg 1988;2077:201-207
8. Moya CE, Guarda LA, Dyer GA, et al. Neuroendocrine carcinoma of the skin in a young adult. Am J Clin Pathol 1982;78:783-785 (Pubitemid 13234550)
9. Shaw JHF, Rumball E. Merkel cell tumor. Clinical behaviour and treatment. Br J Surg 1991;78:138-142
10. Haibach H, Burns TW, Carlson HE, et al. Multiple hamartoma syndrome (Cowden's disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Am J Clin Pathol 1992;97:705-712
11. Grosh WW, Giannone L, Hande KR, et al. Disseminated Merkel cell tumor. Treatment with systemic chemotherapy. Am J Clin Oncol 1987;10:227-230 (Pubitemid 17120761)
12. Engels EA, Frisch M, Goedert JJ, et al. Merkel cell carcinoma and HIV infection Lancet 2002;359:497-498
13. Ratner D, Nelson B, Brown M, et al. Merkel cell carcinoma. J Am Acad Dermatol 1993;29:143-156
14. Yom SS, Rosenthal DI, El-Naggar AK, et al. Merkel cell carcinoma of the tongue and head and neck oral mucosal sites. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:761-768
15. Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008;58:375-381 (Pubitemid 351226308)
16. Raaf JH, Urmarcher C, Knapper WK, et al. Trabecular (Merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease. Cancer 1986;57:178-182
17. Routh A, Hickman BT, Johnson WW. Superior vena cava ostruction from Merkel cell carcinoma. Arch Dermatol 1987;123:714-716
18. Poulsen M, Rischin D, Walpole E, et al. Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Oncology Group Study - TROG 96:07. J Clin Oncol 2003;21:4371-4376 (Pubitemid 46621814)
19. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004;5:593-599
20. Popp S, Waltering S, Herbst C, et al. UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas. Int J Cancer 2002;99:352-360 (Pubitemid 34495849)
21. Smith DF, Messina JL, Perrto L, et al. Clinical approach to neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Cancer Control 2000;7:72-83. (Pubitemid 30102071)
22. Iacocca MW, Abernethy JL, Stefanato CM, et al. Mixed Merkel cell carcinoma and squamous cell carcinoma of the skin. J Am Acad Dermatol 1998;39:882-887 (Pubitemid 28520709)
23. Lunder EJ, Stern RS. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998;339:1247-1248
24. Tsuruta D, Hamada T, Mochida K, et al. Merkel cell carcinoma, Bowen's disease and chronic occupational arsenic poisoning. Br J Dermatol 1998;139:291-294 (Pubitemid 28389405)
25. Bordea C, Wojanarowska F, Millard PR, et al. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004;77:574-579 (Pubitemid 38282815)
26. Manganoni MA, Farisoglio C, Tucci G, et al. Merkel cell carcinoma and HIV infection: a case report and review of the literature. AIDS Patient Care STDS 2007;21:447-451 (Pubitemid 47221640)
27. Brenner B, Sulkes A, Rakowsky E, et al. Second neoplasms in patients with Merkel cell carcinoma. Cancer 2001;91:1358-1362 (Pubitemid 32267048)
28. Kanitakis J, Joly MO, Chouvet B, et al. Merkel cell carcinoma in immunocompetent and organ-transplant recipients do not harbor HPV. Eur J Dermatol 2006;16:445-446 (Pubitemid 44328994)
29. Feng H, Shuda M, Chang Y, et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008;319:1096-1100 (Pubitemid 351300792)
30. Duncavage EJ, Zehnbauer BA, Pfeifer JD. Prevalence of Merkel cell polyomavirus in Merkel cell carcinoma. Mod Pathol 2009;22:516-521
31. Varga E, Kiss M, Szabò K, Kémeny L. Detection of Merkel cell polyomavirus DNA in Merkel cell carcinomas Br J Dermatol 2009;161:330-338
32. Garneski KM, Warcola AH, Feng Q, et al. Merkel cell polyomavirus is more frequently present in North American than Australian Merkel cell carcinoma tumors. J Invest Dermatol 2009;129:246-248
33. Lewe WF, Schaumberg-Lever G. Histopathology of the skin, 7th ed. Philadelphia: JB Lippincott; 1990.
34. Warnick M, Singh S, Boisvert ME, et al. Merkel cell carcinoma presenting as lymphadenopathy without a primary cutaneous lesion: a report of 2 cases. Arch Dermatol 2008;144:1397-1398
35. Plaza JA, Suster S. The Toker tumor: spectrum of morphologic features in primary neuroendocrine carcinomas of the skin (Merkel cell carcinoma). Ann Diagn Pathol 2006;10:376-385 (Pubitemid 44765279)
36. Cheuk W, Kwan MY, Suster S, et al. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 2001;125:228-231 (Pubitemid 32167475)
37. Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000;13:238-242 (Pubitemid 30207508)
38. Schmidt U, Müller U, Metz KA, et al. Cytokeratin and neurofilament protein staining in Merkel cell carcinoma of the small cell type and small cell carcinoma of the lung. Am J Dermatopathol 1998;20:346-351 (Pubitemid 28363615)
39. Su LD, Fullen DR, Lowe L, et al. CD117 (KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 2002;24:289-293 (Pubitemid 34810303)
40. Yang Q, Hornick JL, Granter SR, et al. Merkel cell carcinoma: lack of KIT positivity and implications for the use of imatinib mesylate. Appl Immunohistochem Mol Morphol 2009;17:276-281
41. Asioli S, Righi A, Volante M, et al. p63 expression as a new prognostic marker inMerkel cell carcinoma. Cancer 2007;110:640-647 (Pubitemid 47106154)
42. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 1995;21:669-683
43. Lucarz A, Brand G. Current considerations about Merkel cells. Eur J Cell Biol 2007;86:243-251
44. Sidhu GS, Chandra P, Cassai ND. Merkel cells, normal and neoplastic: an update. Ultrastruct Pathol 2005;29:287-294 (Pubitemid 40993753)
45. Smith PD, Patterson JW. Merkel cell carcinoma (neuroendocrine carcinoma of the skin). Am J Clin Pathol 2001;115 Suppl:S68-78.
46. Van Gele M, Van Roy N, Ronan SG, et al. Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas. Genes Chromosomes Cancer 1998;23:67-71. (Pubitemid 28364220)
47. Leonard JH, Williams G, Walters MK, et al. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma. Genes Chromosomes Cancer 1996;15:102-107 (Pubitemid 26048410)
48. Leonard JH, Hayard N. Loss of heterozygosity of chromosome 13 in Merkel cell carcinoma. Genes Chromosomes Cancer 1997;20:93-97 (Pubitemid 27377105)
49. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol 2002;20:588-598
50. Härle M, Arens N, Moll I, et al. Comparative genomic hybridization (CGH) discloses chromosomal and subchromosomal copy number changes in Merkel cell carcinomas. J Cutan Pathol 1996;23:391-397 (Pubitemid 26364545)
51. Larsimont D, Verhest A. Chromosome 6 trisomy as sole anomaly in a primary Merkel cell carcinoma. Virchows Arch 1996;428:305-309 (Pubitemid 26265754)
52. Carson HJ, Lueck NE, Horten BC. Comparison of mutant and wild-type p53 proteins in Merkel cell carcinoma. Clin Diagn Lab Immunol 2000;7:326.
53. Poulsen M, Round C, Keller J, et al. Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb - a review of 60 cases. Int J Radiat Oncol Biol Phys 2009 Jun 8.[Epub ahead of print]
54. Koljonen V, Böhling T, Granhroth G, et al. Merkel cell carcinoma: a clinicopathological study of 34 patients. Eur J Surg Oncol 2003;29:607.
55. Allen PJ, Zhang ZF, Coit DG. Surgical management of Merkel cell carcinoma. Ann Surg 1999;229:97-105. (Pubitemid 30190386)
56. Morrison WH, Peters LJ, Silva EG, et al. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990;19:583-591
57. Henness S, Vereecken P. Management of Merkel tumours: an evidence-based review. Curr Opin Oncol 2008;20:280-286 (Pubitemid 351507548)
58. Gollub MJ, Gruen DR, Dershaw DD. Merkel cell carcinoma: CT findings in 12 patients. AJR Am J Roentgenol 1996;167:617-620 (Pubitemid 26279699)
59. Catalano O, Catalano G, Nunziata A. The echographic and computed radiographic findings in 2 cases of Merkel-cell carcinoma. Radiol Med 1997;94:529-530 (Pubitemid 128520012)
60. Ortin-Perez J, van Rijk MC, Valdes-Olmos RA, et al. Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Eur J Surg Oncol 2007;33:119-122 (Pubitemid 46131870)
61. Warner RE, Quinn MJ, Hruby G, et al. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 2008;15:2509-2518
62. Allen PJ, Bowene WB, Jaques DP, et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005;23:2300-2309 (Pubitemid 46218722)
63. Gupta SG, Wang LC, Peñas PF, et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006;142:685-690 (Pubitemid 43920632)
64. Warner RE, Quinn MJ, Hruby G, et al. Lymphatic mapping and sentinel node biopsy in Merkel's cell carcinoma. Ann Surg Oncol 2008;15:2509-2518
65. Mehrany K, Otley CC, Weenig RH, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113-117 (Pubitemid 34177347)
66. Guitera-Rovel P, Lumbroso J, Gautier-Gougis MS, et al. Indium-111 octreotide scintigraphy of Merkel cell carcinomas and their metastases. Ann Oncol 2001;12:807-811 (Pubitemid 32655090)
67. Belhocine T, Pierard GE, Frühling J, et al. Clinical added-value of 18FDG PET in neuroendocrine-Merkel cell carcinoma. Oncol Rep 2006;16:347-352
68. Miller SJ, Alam M, Andersen J, et al. Merkel cell carcinoma. J Natl Compr Canc Netw 2009;7:322-332
69. Kokoska ER, Kokoska MS, Collins BT, et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997;174:688-693 (Pubitemid 28008704)
70. Yiengpruksawan A, Coit DG, Thaler HT, et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991;126:1514-1519
71. Shaw JH, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991;78:138-142
72. Bichakjian CK, Lowe L, Lao CD, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007;110:1-12. (Pubitemid 46986412)
73. Boyer JD, Zitelli JA, Brodland DG, et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002;47:885-892
74. Medina-Franco H, Urist MM, Fiveash J, et al. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol 2001;8:204-208 (Pubitemid 32294799)
75. Venness MJ, Perera L, McCourt J, et al. Merkel cell carcinoma improved outcome with adijuvant radiotherapy. Aust N Z J Surg 2005;75:275-281 (Pubitemid 40826890)
76. Gillenwater AM, Hessel AC, Morrison WH, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001;127:149-154
77. Guihard S, Nöel G. Merkel cell carcinoma, role of radiotherapy and literature review. Cancer Radiother 2009;13:47-54.
78. Hill AD, Brady MS, Cot DG. Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg 1999;86:518-521 (Pubitemid 29195050)
79. Messina JL, Reitgens D, Cruse CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997;4:389-395 (Pubitemid 127725513)
80. Mehrany K, Otley CC, Weening RH, et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002;28:113-7; discussion 117.
81. Poulsen MG, Rischin D, Porter I, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys 2006;64:114-119
82. Wood BC, Kleinpeter KP, Levine EA. Treatment of in-transit metastases from Merkel cell carcinoma with isolated hyperthermic limb perfusion. Am Surg 2007;73:1291-1292
83. Grandpeix C, Bonvalot S, Petrow P, et al. Continued complete remission of Merkel cell carcinoma with in-transit metastasis after treatment with isolated limb perfusion regional chemotherapy. Ann Dermatol Venereol 2006;133:700-703 (Pubitemid 44401077)
84. Grobmyer SR, Copeland EM 3rd, Hochwald SN. Treatment of intransit metastases from Merkel cell carcinoma with isolated hyperthermic limb infusion. Am Surg 2008;74:1222-1223
85. Voog E, Biron P, Martin JP, et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999;85:2589-2595 (Pubitemid 29272745)
86. Tai PT, Yu E, Winquist E, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000;18:2493-2499 (Pubitemid 30415837)
87. Pectasides D, Pectasides M, Psyrri A, et al. Cisplatin-based chemotherapy for Merkel cell carcinoma of the skin. Cancer Invest 2006;24:780-785 (Pubitemid 44949881)
88. Poulsen M, Walpole E, Harvey J, et al. Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin. Int J Radiat Oncol Biol Phys 2008;72:1070-1074
89. Fenig E, Lurie H, Sulkes A. The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol 1993;16:54-57 (Pubitemid 23074783)
90. Fenig E, Brenner B, Katz A, et al. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer 1997;80:881-885 (Pubitemid 27360469)
91. Wobser M, Kürzinger N, Ugurel S, et al. Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy. J Dtsch Dermatol Ges 2009;7:521-525
92. Bajetta E, Rimassa L, Carnaghi C, et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer 1998;83:372-378 (Pubitemid 28317819)
93. Crown J, Lipzstein R, Cohen S, et al. Chemotherapy of metastatic Merkel cell cancer. Cancer Invest 1991;9:129-132
94. Mortier L, Mirabel X, Ferte C, et al. Merkel cell carcinoma: current diagnosis and treatment. Bull Cancer 2008;95:823-827
95. Feun LG, Savaraj N, Legha SS, et al. Chemotherapy for metastatic Merkel cell carcinoma. Review of the M.D. Anderson Hospital's experience. Cancer 1988;62:683-685
96. Bajetta E, Rimassa L, Carnaghi C, et al. 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer 1998;83:372-378 (Pubitemid 28317819)
97. O'Brien ME, Ciuleanu TE, Tsekov H, et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 2006;24:5441-5447 (Pubitemid 46623178)
98. Kulke MH, Wu B, Ryan DP, et al. A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors. Dig Dis Sci 2006;51:1033-1038 (Pubitemid 44127047)
99. Ansell SM, Mahoney MR, Green EM, et al. Topotecan in patients with advanced neuroendocrine tumors: a phase II study with significant hematologic toxicity. Am J Clin Oncol 2004;27:232-235
100. Yamamoto N, Tsurutani J, Yoshimura N, et al. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer. Anticancer Res 2006;26 Suppl 1B:777-781 (Pubitemid 43206048)
101. Clippe C, Ligneau B, Trillet-Lenoir V. Role of gemcitabine in the treatment of other malignant tumors. [Special Issue] Bull Cancer 2002;89:S120-2.
102. Dyrix LY, Prove A, Becquart D, et al. Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma. Cancer 1991;67:2207-2210
103. Ruan JH, Reeves M. A Merkel cell carcinoma treatment algorithm. Arch Surg 2009;144:582-585